EMEA-000468-PIP02-12-M07
Key facts
| Invented name |
Noxafil
|
| Active substance |
posaconazole
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0196/2022
|
| PIP number |
EMEA-000468-PIP02-12-M07
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
E-mail: pip.information@merck.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|